Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors
申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0409163A2
公开(公告)日:1991-01-23
Novel cyclic vinylogous N-hydroxy-N-methylureas are useful in the treatment of leukotriene mediated conditions such as asthma and rheumatoid arthritis.
Novel cyclic vinylogous N-hydroxy-N-methylureas are useful in the treatment of leukotriene mediated conditions such as asthma and rheumatoid arthritis.